Rubinstein-Taybi syndrome due to EP300 haploinsufficiency: genes and variants

Explore variant evidence for Rubinstein-Taybi syndrome due to EP300 haploinsufficiency across 1 analyzed protein (EP300). Linked ClinVar records include 17 pathogenic or likely pathogenic variants, 315 variants of uncertain significance and 89 with conflicting classifications.

Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.

Data updated 2026-11-05. Automated aggregation, not a clinical review date.

Download variant evidence (CSV)

Genes linked to Rubinstein-Taybi syndrome due to EP300 haploinsufficiency

Weakly linked (only a few uncertain records): PANK2.

Where Rubinstein-Taybi syndrome due to EP300 haploinsufficiency variants cluster

ClinVar pathogenic and likely pathogenic variants linked to Rubinstein-Taybi syndrome due to EP300 haploinsufficiency

VariantPositionProtein partClinical label
EP300 M1588T1588CBP/p300-type HATPathogenic / likely pathogenic (★★)
EP300 F1595V1595CBP/p300-type HATPathogenic / likely pathogenic (★★)
EP300 T887I887Pathogenic / likely pathogenic (★★)
EP300 N1286S1286Pathogenic / likely pathogenic (★★)
EP300 R1831T1831Pathogenic / likely pathogenic (★)
EP300 R1831S1831Pathogenic / likely pathogenic (★)
EP300 R1829P1829Pathogenic / likely pathogenic (★)
EP300 R580Q580KIXPathogenic / likely pathogenic (★)
EP300 R1197W1197Pathogenic / likely pathogenic (★)
EP300 G1375V1375CBP/p300-type HATPathogenic / likely pathogenic (★)
EP300 T1411I1411CBP/p300-type HATPathogenic / likely pathogenic (★)
EP300 P1440T1440CBP/p300-type HATPathogenic / likely pathogenic (★)
EP300 H1451Y1451CBP/p300-type HATPathogenic / likely pathogenic (★)
EP300 F1504C1504CBP/p300-type HATPathogenic / likely pathogenic (★)
EP300 D1507E1507CBP/p300-type HATPathogenic / likely pathogenic (★)
EP300 R1627W1627CBP/p300-type HATPathogenic / likely pathogenic (★)
EP300 R1391S1391CBP/p300-type HATPathogenic / likely pathogenic

Which prediction tools work for Rubinstein-Taybi syndrome due to EP300 haploinsufficiency

Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.

Same protein, different disease

Diseases related to Rubinstein-Taybi syndrome due to EP300 haploinsufficiency

Frequently asked questions

Which genes have records linked to Rubinstein-Taybi syndrome due to EP300 haploinsufficiency?

This view contains 1 analyzed proteins: EP300. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.

What do the clinical classifications mean?

Linked records include 17 pathogenic or likely pathogenic variants, 315 variants of uncertain significance and 89 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.

Does the evidence score change a VUS classification?

No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.

Can I download the variant evidence?

Download the CSV for all 667 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center